Cystic fibrosis Trials in Billings, United States
Conditions / Cystic fibrosis / Billings, United States
Clinical trials for Cystic fibrosis investigate a range of treatment strategies and patient populations.
15 total trials for this combination
Showing top 10 of 15 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06504589 | A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators | RECRUITING | — |
| NCT03525444 | A Phase 3 Study of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF) | COMPLETED | PHASE3 |
| NCT03525574 | A Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy | COMPLETED | PHASE3 |
| NCT06350474 | Impact of Discontinuing Dornase Alfa in People With CF on Highly Effective CFTR Modulator Therapy-A SIMPLIFY Sub-Study | COMPLETED | NA |
| NCT05548283 | Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study | RECRUITING | PHASE4 |
| NCT04378153 | Impact of Discontinuing Chronic Therapies in People With Cystic Fibrosis on Highly Effective CFTR Modulator Therapy | COMPLETED | — |
| NCT05444257 | A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT05033080 | A Phase 3 Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Heterozygous for F508del and a Minimal Function Mutation (F/MF) | COMPLETED | PHASE3 |
| NCT06350461 | Impact of Discontinuing Hypertonic Saline in People With CF on Highly Effective CFTR Modulators- A SIMPLIFY Sub-Study | COMPLETED | NA |
| NCT05076149 | A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del Mutation | COMPLETED | PHASE3 |